Paul B. Manning, Director, 10% Owner at Verrica Pharmaceuticals Inc. (VRCA), bought 400,000 shares at $5.02 ($2.0M) on 2023-07-24, disclosed to the SEC on 2023-07-24.
Open-market purchase of $2.0M VRCA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.02 | 200,000 | $1.0M | 50.0% |
| 2 | $5.02 | 200,000 | $1.0M | 50.0% |
| Total | $5.02 avg | 400,000 | $2.0M | 100% |
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| TSHA | BUY | 2025-06-03 | $2.1M | — | Filing → |